These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Botulinum toxin. Development for therapeutic purposes]. Ceballos-Baumann A Nervenarzt; 2008 Jun; 79 Suppl 1():3-8. PubMed ID: 18927957 [TBL] [Abstract][Full Text] [Related]
5. A new indication of botulinum toxin: leiomyoma-related pain. Onder M; Adişen E J Am Acad Dermatol; 2009 Feb; 60(2):325-8. PubMed ID: 19150277 [TBL] [Abstract][Full Text] [Related]
6. Botulinum toxin in movement disorders. Papapetropoulos S; Singer C Semin Neurol; 2007 Apr; 27(2):183-94. PubMed ID: 17390263 [TBL] [Abstract][Full Text] [Related]
7. Gynecological indications for the use of botulinum toxin in women with chronic pelvic pain. Abbott J Toxicon; 2009 Oct; 54(5):647-53. PubMed ID: 19264089 [TBL] [Abstract][Full Text] [Related]
8. New therapeutic indications for botulinum toxins. Cordivari C; Misra VP; Catania S; Lees AJ Mov Disord; 2004 Mar; 19 Suppl 8():S157-61. PubMed ID: 15027069 [TBL] [Abstract][Full Text] [Related]
9. Botulinum toxin in post-stroke patients: stiffness modifications and clinical implications. Miscio G; Del Conte C; Pianca D; Colombo R; Panizza M; Schieppati M; Pisano F J Neurol; 2004 Feb; 251(2):189-96. PubMed ID: 14991354 [TBL] [Abstract][Full Text] [Related]
10. Serial injection of botulinum toxin for muscle imbalance due to regional spasticity in the upper limb. Turner-Stokes L; Ashford S Disabil Rehabil; 2007 Dec; 29(23):1806-12. PubMed ID: 18033605 [TBL] [Abstract][Full Text] [Related]
11. The effects of botulinum toxin in spasticity and headaches: a common key? Sandrini G Funct Neurol; 2008; 23(2):61. PubMed ID: 18671904 [No Abstract] [Full Text] [Related]
12. Application of botulinum toxin to clinical therapy: advances and cautions. Levy NS; Lowenthal DT Am J Ther; 2012 Jul; 19(4):281-6. PubMed ID: 22481607 [TBL] [Abstract][Full Text] [Related]
13. Botulinum toxin type A for upper limb spasticity following stroke: an open-label study with individualised, flexible injection regimens. Slawek J; Bogucki A; Reclawowicz D Neurol Sci; 2005 Apr; 26(1):32-9. PubMed ID: 15877185 [TBL] [Abstract][Full Text] [Related]
14. [Spasticity and botulinum toxin in 2003. An update]. Fève A Neurochirurgie; 2003 May; 49(2-3 Pt 2):265-70. PubMed ID: 12746701 [TBL] [Abstract][Full Text] [Related]
15. The use of botulinum toxin in physical medicine and rehabilitation. Cuevas-Trisán RL; Cruz-Jiménez M Bol Asoc Med P R; 2006; 98(1):42-55. PubMed ID: 19610549 [TBL] [Abstract][Full Text] [Related]
16. [Botulinum toxin for the treatment of pain syndromes]. Ferreira JJ; Couto M; Costa J; Coelho M; Rosa MM; Sampaio C Acta Reumatol Port; 2006; 31(1):49-62. PubMed ID: 17058384 [TBL] [Abstract][Full Text] [Related]
18. A new wrinkle on pain relief: re-engineering clostridial neurotoxins for analgesics. Foster KA Drug Discov Today; 2005 Apr; 10(8):563-9. PubMed ID: 15837599 [TBL] [Abstract][Full Text] [Related]
19. Dystonia and headaches: clinical features and response to botulinum toxin therapy. Galvez-Jimenez N; Lampuri C; Patiño-Picirrillo R; Hargreave MJ; Hanson MR Adv Neurol; 2004; 94():321-8. PubMed ID: 14509690 [No Abstract] [Full Text] [Related]
20. Effectivity of Dysport in patients with blepharospasm and hemifacial spasm who experienced failure with Botox. Badarny S; Susel Z; Honigman S Isr Med Assoc J; 2008 Jul; 10(7):520-2. PubMed ID: 18751631 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]